Deerfield Mgmt, L.P. 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 5:32 pm Purchase | 2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Deerfield Mgmt, L.P. | 5,788,024 7.190% | 1,160,714 (+25.08%) | Filing |
| 2023-03-22 4:17 pm Purchase | 2023-03-13 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Deerfield Mgmt, L.P. | 4,627,310 6.090% | 2,278,082 (+96.97%) | Filing |
| 2023-02-10 09:42 am Sale | 2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Deerfield Mgmt, L.P. | 2,349,228 3.480% | -3,231,228 (-57.90%) | Filing |
| 2022-02-11 4:10 pm Purchase | 2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Deerfield Mgmt, L.P. | 5,580,456 9.540% | 1,376,556 (+32.74%) | Filing |
| 2021-11-10 4:59 pm Purchase | 2021-11-05 | 13G | Deciphera Pharmaceuticals, Inc. DCPH | Deerfield Mgmt, L.P. | 4,203,900 7.190% | 4,203,900 (New Position) | Filing |